Developing drugs for cancer is a process as complex the disease itself. At planning stage of clinical trial an oncology drug, thorough and careful consideration must be given to choosing right study design endpoints/estimands, any bias introduced at outset would cascade down analysis eventually reporting results. The common designs drugs, their challenges, current perspectives (and dilemmas) in...